Abstract
The mechanisms underlying chronic kidney disease (CKD)–associated higher risks for life-threatening ventricular tachyarrhythmias remain poorly understood. In rats subjected to unilateral nephrectomy (UNx), we examined cardiac electrophysiological remodeling and relevant mechanisms predisposing to ventricular arrhythmias. Adult male Sprague-Dawley rats underwent UNx (n = 6) or sham (n = 6) operations. Eight weeks later, the UNx group had higher serum blood urea nitrogen and creatinine levels and a longer electrocardiographic QTc interval than did the sham group. Patch-clamp studies revealed epicardial (EPI)-predominant prolongation of the action potential duration (APD) at 50% and 90% repolarization in UNx EPI cardiomyocytes compared to sham EPI cardiomyocytes. A significant reduction of the transient outward potassium current (Ito) in EPI but not in endocardial (ENDO) cardiomyocytes of UNx rats led to a decreased transmural gradient of Ito. The reduction of Ito currents in UNx EPI cardiomyocytes was secondary to downregulation of KChIP2 but not Kv4.2, Kv4.3, and Kv1.4 protein expression. Incubation of plasma electronegative low-density lipoprotein (LDL) from UNx rats with normal EPI and ENDO cardiomyocytes recapitulated the electrophysiological phenotype of UNx rats. In conclusion, CKD disrupts the physiological transmural gradient of Ito via downregulation of KChIP2 proteins in the EPI region, which may promote susceptibility to ventricular tachyarrhythmias. Electronegative LDL may underlie downregulation of KChIP2 in CKD.
Similar content being viewed by others
Introduction
Annual cardiovascular mortality in patients with chronic kidney disease (CKD) is much higher than that in the general population1,2. Sudden cardiac death (SCD) is the leading cause of cardiovascular mortality and may be responsible for 60% of cardiac deaths in patients undergoing dialysis3,4. The most common electrical mechanism leading to SCD involves the interaction of a triggering event and an abnormal cardiac substrate that induces ventricular tachycardia (VT), which degenerates into ventricular fibrillation (VF)5,6. Alternatively, SCD can be initiated directly by VF or polymorphic VT. SCD associated with bradyarrhythmias or asystole, often presenting as electromechanical dissociation, is less frequent and usually occurs in the setting of advanced heart failure5,6.
Even mild changes in renal function increase the risk of SCD, especially in older populations7; however, the mechanisms underlying this increased risk are unclear but may be attributed to the complications of atherosclerosis8. However, not all SCD cases are directly related to vascular dysfunction and myocardial infarction, suggesting the presence of other causes contributing to SCD9. Recently, Hsueh et al. used optical mapping to demonstrate the occurrence of abnormalities of cardiac electrical remodeling in a rat model of CKD10. The remodeling consisted of the loss of repolarization reserve and the presence of intracellular calcium abnormalities, which together may predispose to arrhythmia and SCD. However, the underlying mechanism is still unclear.
CKD may lead to dysregulation of key enzymes, transfer proteins, and receptors involved in lipoprotein metabolism; these changes cause multiple lipoprotein abnormalities11, which may occur during the early stages of CKD12,13. Dyslipidemia in CKD, characterized by high triglyceride and low high-density lipoprotein (HDL) levels and accumulation of small dense low-density lipoprotein (LDL) particles, is a shared risk factor for the development and progression of both CKD and cardiovascular diseases14. Our previous study showed that increased LDL electronegativity in CKD disrupts calcium homeostasis, resulting in cardiac diastolic dysfunction15. Furthermore, it has been reported that incubation of guinea pig ventricular myocytes with oxidized-LDL led to changes in electrophysiological properties including prolongation of the action potential duration (APD), depolarization of resting membrane potential, and modification of transmembrane ion currents16. Thus, in the present study, we hypothesize that electronegative LDL may play an important role in CKD-induced cardiac electrical remodeling.
Here, we have analyzed the electronegativity of plasma LDL and cardiac electrical remodeling in a rat model of early-stage CKD induced by unilateral nephrectomy (UNx) in both in vitro and in vivo experiments. To clarify the underlying electrophysiological mechanisms of CKD-related arrhythmia and SCD, we compared the characteristics of the transmural gradient of the APD and ion channels between cardiomyocytes isolated from the epicardial (EPI) and endocardial (ENDO) region by using the patch-clamp technique. The kinetic properties and protein expression levels of Kv1.4, Kv4.2, Kv4.3, and KChIP2 were also examined to investigate a possible influence of the repolarization K+ current in this animal model of CKD. Importantly, we compared the effects of LDL isolated from sham and UNx rats on freshly isolated rat cardiomyocytes to assess a causative role of electronegative LDL on CKD-related cardiac electrical remodeling.
Results
UNx rats exhibited prolonged QT intervals
We performed UNx on 6 adult Sprague-Dawley rats to create a rat model of early-stage CKD, and we performed a sham operation on 6 control rats. Eight weeks after the operation, body weight and total cholesterol, triglyceride, LDL, and HDL levels were not significantly different between UNx and sham rats (Table 1). However, blood urea nitrogen (BUN) and creatinine levels were significantly higher in UNx rats than in the sham group (P = 0.04 and P < 0.01, respectively). For surface electrocardiographic characteristics, the RR interval, heart rate, PR interval, P duration, and QRS interval were similar between UNx and sham rats (Fig. 1a). However, the QT interval and corrected QT interval (QTc) were prolonged by about 60% in UNx rats (0.082 ± 0.003 and 0.060 ± 0.002, respectively). We used Mitchell’s approach for the QTc analysis, which has been widely used at fast heart rates with consistent results in rodents17.
Action potential duration was prolonged in EPI but not ENDO UNx cardiomyocytes
To further study the mechanisms involved in QT prolongation in UNx rats, we first compared action potentials between EPI and ENDO cardiomyocytes from sham and UNx rats by using the patch-clamp technique. Cardiomyocytes were paced with 3–5 ms suprathreshold depolarizing stimuli in the current-clamp mode. Figure 1b shows the superimposed recordings of action potentials for UNx and sham rat EPI and ENDO cardiomyocytes. The APD at 50% and 90% repolarization was longer in UNx EPI cardiomyocytes than in sham EPI cardiomyocytes (P = 0.048 and P = 0.008, respectively; Fig. 1c), but not significantly different between UNx and sham ENDO cardiomyocytes. No significant differences were observed between UNx and sham rat cardiomyocytes in action potential amplitude and resting membrane potential (Fig. 1d).
Disruption of the transmural gradient of Ito by UNx
The transient outward potassium current (Ito) of cardiomyocytes isolated from ENDO and EPI regions of sham and UNx rats were recorded in the voltage-clamp mode (Fig. 2a). To determine Ito, we elicited cardiomyocytes by a 10 ms step to −40 mV from the holding potential of −80 mV (to inactivate sodium channel), followed by a 400-ms depolarization to various potential levels ranging from −60 to 60 mV (applied at 20 mV increments every 1 s). The contamination of the calcium current was prevented by adding 1 mM Co2+ (Fig. 2b). Current-voltage relationships showed that Ito density was much larger in EPI than in ENDO cardiomyocytes in both sham and UNx rats, as predicted (Fig. 2c and d). However, EPI cardiomyocytes isolated from UNx showed a significantly smaller Ito at 60, 40, and 20 mV than those isolated from the corresponding layer in sham rats (P = 0.041, 0.033, and 0.045, respectively; Fig. 2c). In ENDO myocytes Ito density was similar in both groups (Fig. 2d). Figure 2e illustrates plots of the transmural gradient (EPI–ENDO) of Ito at different voltages from −60 to +60 mV for sham and UNx myocytes. The gradient was significantly smaller in cardiomyocytes from UNx than from sham animals (P = 0.021). We found no significant differences between sham and UNx cardiomyocytes in the ICa (−8.88 ± 1.02 vs. −9.57 ± 1.11 pA/pF at 10 mV, respectively; P = 0.649) and the IK1 currents (−38.16 ± 4.45 vs. −33.56 ± 2.51 pA/pF at −140 mV, respectively; P = 0.081) (Supplementary Fig. S1). In addition, sham LDL- and UNx LDL-treated normal cardiomyocytes had similar ICa (−18.99 ± 1.86 vs. −18.86 ± 3.41 pA/pF at 10 mV, respectively; P = 0.947) and IK1 currents (−32.11 ± 1.29 vs. −32.61 ± 2.43 pA/pF at −140 mV, respectively; P = 0.866) (Supplementary Fig. S2). Moreover, the midpoint of inactivation of ICa was similar between sham and UNx rats (−16.50 ± 1.90 vs. −16.23 ± 2.41; P = 0.933) and between sham LDL- and UNx LDL-treated cardiomyocytes (−16.00 ± 1.73 vs. −18.19 ± 2.76; P = 0.527) (Supplementary Fig. S3).
Change in Ito gating properties in EPI cardiomyocytes from UNx rats
Because the smaller current density seen in EPI cardiomyocytes from UNx rats may be due to altered channel kinetics, we examined the gating properties of Ito. To examine the voltage dependence of inactivation of Ito, we used different voltages of conditioning pulses (−100 to +20 mV), which either depolarized or hyperpolarized from the holding potential of −80 mV for 1 second to inactivate the channel; with the second pulse, we depolarized to +60 mV for 200 ms from different precondition pulses (Fig. 3a). Figure 3b shows representative traces of Ito after different preconditioning voltages in EPI cardiomyocytes from sham and UNx rats. Ito amplitude normalized to the Ito of the most negative conditioning pulse (Imax) was plotted against the conditioning voltage in Fig. 3c, and the curve was fitted by a Boltzmann model to obtain the midpoint of inactivation. We showed that the curve of UNx EPI cardiomyocytes was left-shifted and that the midpoint of inactivation was more negative than that of the sham group (P = 0.0004; Fig. 3d). For the kinetics of Ito recovery from inactivation, we used a typical 2-pulse protocol. Two identical pulses (from a holding potential of −80 mV to the test potential of +60 mV for 200 ms) were elicited in a variable interval from 0 to 200 ms in 20-ms increments (Fig. 3e). Representative traces of both sham and UNx EPI cardiomyocytes are provided in Fig. 3f, which showed Ito recovered from inactivation at a much slower rate in EPI cardiomyocytes from UNx rats than in those from the sham group. Normalized currents were plotted against the interval between the two pulses, and the data were fitted by a single exponential equation (Fig. 3g). The time constant (τ) of UNx EPI cardiomyocytes was significantly increased when compared to that in the sham group (P = 0.04; Fig. 3h). In ENDO cardiomyocytes, the inactivation and recovery curves of sham and UNx were comparable, and there were no significant differences between the two groups (data not shown).
Incubation of LDL from UNx rats prolonged action potential in normal EPI but not ENDO cardiomyocytes
To clarify the underlying mechanisms of UNx-induced electrophysiologic remodeling and to determine whether circulating LDL plays an important role, we compared the electronegativity of LDL between sham and UNx rats. The results of agarose gel electrophoresis showed that the LDL from UNx rats was more electronegative than that from healthy controls (Fig. 4a). We then incubated normal EPI cardiomyocytes with 100 μg/mL LDL from sham or UNx rats for 12 hours. Figure 4b shows the superimposed recordings of action potentials for UNx LDL- and sham LDL-treated normal EPI and ENDO cardiomyocytes. The APD at 50% and 90% repolarization was longer in UNx LDL-treated than in sham LDL-treated EPI cardiomyocytes (P = 0.002 and P = 0.0001, respectively; Fig. 4c) but was not significantly different between UNx LDL- and sham LDL-treated ENDO cardiomyocytes. No significant differences were observed in action potential amplitude and resting membrane potential between UNx LDL- and sham LDL-treated EPI and ENDO cardiomyocytes (Fig. 4d).
Incubation of EPI myocytes with LDL from UNx but not sham rats reduced Ito density and its transmural gradient
The transient outward potassium current (Ito) of both EPI and ENDO cardiomyocytes treated with sham LDL and UNx LDL was recorded (Fig. 5a). For the determination of Ito, we elicited cardiomyocytes by a 10 ms step to −40 mV from the holding potential of −80 mV, followed by 400 ms depolarization to various potential levels ranging from −60 to 60 mV (applied at 10 mV increments every 1 s) (Fig. 5b). Current-voltage relationships showed that Ito density at 60, 50, 40, and 30 mV was significantly smaller in UNx LDL-treated EPI cardiomyocytes than in sham LDL-treated EPI cardiomyocytes (P = 0.020, 0.038, 0.038, and 0.045, respectively; Fig. 5c). In ENDO cardiomyocytes Ito density was similar in both groups (Fig. 5d). Figure 5e shows the plots of the transmural gradient of Ito at different voltages from −60 to +60 mV for sham LDL- and UNx LDL-treated cardiomyocytes. The gradient was significantly smaller in UNx LDL-treated cardiomyocytes than in sham LDL-treated cardiomyocytes (P = 0.029).
Incubation of EPI cardiomyocytes with LDL from UNx but not sham rats alters Ito so that its gating properties resemble those found in UNx EPI cardiomyocytes
We compared the gating properties of Ito between sham LDL- and UNx LDL-treated cardiomyocytes to clarify the mechanism underlying Ito downregulation. To examine the voltage dependence of inactivation of Ito, we used different voltages of conditioning pulses (−100 to +20 mV), which either depolarized or hyperpolarized from the holding potential of −80 mV for 1 second to bring the membrane to inactivation; with the second pulse, we depolarized to +60 mV for 200 ms from different precondition pulses (Fig. 6a). Figure 6b shows representative traces of Ito after different preconditioning voltages in sham LDL- and UNx LDL-treated EPI cardiomyocytes. Ito amplitude normalized to the Ito of the most negative conditioning pulse (Imax) was plotted against conditioning voltage in Fig. 6c, and the curve was fitted by a Boltzmann model to obtain the midpoint of inactivation. We showed that the curve of UNx LDL-treated EPI cardiomyocytes was left-shifted and that the midpoint of inactivation was more negative than that of the sham LDL group (P = 0.002; Fig. 6d). For the kinetics of Ito recovery from inactivation, we used a typical 2-pulse protocol. Two identical pulses (from holding potential of −80 mV to the test potential of +60 mV for 200 ms) were elicited in variable intervals from 0 to 140 ms in 10-ms increments (Fig. 6e). Representative traces of both sham LDL- and UNx LDL-treated EPI cardiomyocytes are presented in Fig. 6f, which shows Ito recovered from inactivation at a much slower rate in UNx LDL-treated EPI cardiomyocytes than in the sham LDL-treated group. Normalized currents were plotted against the interval between two pulses, and the data were fitted by a single exponential equation (Fig. 6g). The time constant (τ) of UNx LDL-treated EPI cardiomyocytes was significantly increased when compared to that of the sham LDL group (P = 0.02; Fig. 6h). Similar to those found in UNx ENDO cardiomyocytes, the inactivation and recovery curves of sham LDL- and UNx LDL-treated cardiomyocytes were comparable, and there were no significant differences between the groups (data not shown).
KChIP2 downregulation in EPI layer of UNx rats and UNx LDL-treated EPI cardiomyocytes
To determine the mechanism underlying changes of Ito channel properties in the EPI layer of UNx rats and UNx LDL-treated EPI cardiomyocytes, we examined the expression levels of Kv4.3, Kv4.2, Kv1.4, and KChIP2 proteins in the EPI layer from sham or UNx rats (Fig. 7a) and sham LDL- or UNx LDL-treated EPI cardiomyocytes (Fig. 7b). In EPI cardiomyocytes from UNx rats, the expression of Kv4.3, Kv4.2, and Kv1.4 proteins was comparable with that in sham myocytes, suggesting that Kv α-subunits did not contribute to the downregulation of Ito. However, the expression of β-subunits KChIP2 protein was significantly reduced in UNx EPI cardiomyocytes compared to sham cardiomyocytes (P = 0.017). Similarly, 100 μg/mL UNx LDL incubation could reduce KChIP2 protein expression (P = 0.0001) but did not change Kv4.3, Kv4.2, and Kv1.4 expression in control EPI cardiomyocytes. There were no significant differences in both α- and β-subunits of Ito between ENDO cardiomyocytes from sham and UNx rats or between sham LDL- and UNx LDL-treated ENDO cardiomyocytes (data not shown).
Discussion
In rats with UNx-induced CKD, we have demonstrated electrocardiographic QTc prolongation in vivo that is mediated by a predominant lengthening of the APD in EPI cardiomyocytes. The differential reduction of Ito currents between EPI and ENDO cardiomyocytes in UNx rats, along with the resultant disruption of the physiological transmural gradient of Ito, may contribute to the APD phenotype. The electrophysiological remodeling with substantial Ito reduction and alteration of transmural Ito gradient in epicardial cardiomyocytes was reproduced in UNx-LDL treated cardiomyocytes. The reduction of Ito is not due to altered expression levels of Kv4.3, Kv4.2, or Kv1.4 proteins, but rather it is related to downregulation of the Kv channels regulator KChIP2. Taken together, the predominant downregulation of KChIP2 protein and Ito currents in EPI cardiomyocytes led to alteration of the transmural Ito gradient, which may create a vulnerable substrate for generating life-threatening ventricular tachyarrhythmias in CKD.
QTc prolongation in CKD
The progression of CKD has been associated with a significant delay of cardiac repolarization manifested by QTc prolongation, independent of other risk factors or structural heart diseases in humans18. The prolongation of QTc can occur even in patients with early-stage CKD (stage 2)19. The abnormalities in cardiac repolarization may thus predispose susceptible CKD patients to fatal ventricular tachyarrhythmias. In support of the human data, in a rat model of CKD with a defect in the samcystin gene (Cy/+), Hsueh et al.10 showed that the APD at 80% of repolarization was longer in CKD rats than in normal rats. Pacing cycle length thresholds to induce calcium transient alternans or APD alternans were also longer in CKD rats. This electrophysiological remodeling led to increased vulnerability to ventricular arrhythmia characterized by the spontaneous occurrence of premature ventricular complexes and a higher frequency of VF induction. Although this model of genetic defect–induced CKD has shown some remodeling abnormalities including altered repolarization reserve and calcium homeostasis by optical mapping technique, the underlying mechanism remains unclear.
In contrast to the study by Hsueh et al., we used a standard UNx-induced CKD model to examine CKD-related cardiac electrophysiological remodeling by the patch-clamp technique. In rodents, APD has been determined mostly by the density of the Ca2+ -independent Ito current20. However, Ito is not uniformly distributed among the whole ventricle. Rather, Ito is more prominent in the sub-epicardial region than in the sub-endocardial tissue in rodent hearts, which causes the baseline APD to be shorter in the EPI region than in the ENDO region21. During some pathological conditions, such as cardiac hypertrophy, the regional difference of Ito reduction can reverse the gradient in APD and ultimately contribute to the increased susceptibility to ventricular arrhythmias22,23. In this early-stage CKD model, we demonstrated that the overall electrocardiographic QTc was prolonged in CKD rats compared to sham-operated rats; this prolongation was mediated by an extensive lengthening of APD in EPI cardiomyocytes compared with ENDO cardiomyocytes and was secondary to a substantial reduction of Ito in the EPI region. The finding that modulation of Ito leads to prolongation or abbreviation of APD was concordant with the observation by Li et al.24, who showed that ablation of cold-inducible, RNA-binding protein–mediated Ito amplification shortened the QTc interval in rats. In the current study, the changes in electrophysiological properties in CKD rats occurred independently of ventricular fibrosis because fibrosis levels were similar in CKD and control rats, as shown by histologic staining and examination of early fibrosis markers15. This electrophysiological remodeling in CKD rats also occurred regardless of cellular hypertrophy based on the finding of similar cellular capacitance in isolated single ventricular cardiomyocytes by the patch-clamp technique (200.69 ± 9.62 in sham vs. 190.37 ± 12.07 pA/pF in UNx). Moreover, Yu et al. found that the renin-angiotensin-aldosterone system (RAAS) could alter the transmural gradient of Ito between EPI and ENDO cardiomyocytes by changing channel kinetics25. In our CKD model, the levels of renin, angiotensin, and aldosterone were not significantly different between UNx and sham rats15. This finding indicates that the electrophysiological remodeling seen in UNx rats was not mediated by modulation of the RAAS.
KChIP2 downregulation disrupts physiological transmural gradient of Ito in CKD
There are species-specific differences in voltage-gated K+ channel expression that are responsible for the timely control of cardiac repolarization. Downregulation of these currents results in prolongation of the APD and a decrease in phase 1 repolarization26. Significant levels of mRNA encoding the rapidly inactivating K+ channel α-subunits Kv1.4, Kv4.2, and Kv4.3 proteins have been seen in rat ventricle27. In addition, previous studies have identified three classes of distinctive cytoplasmic auxiliary proteins, including KChIPs, Kv β-subunits, and KChAP. These proteins not only incorporate with specific Kv α-subunits to generate the native Ito current, but also regulate functional expression of these channels in vitro28,29,30.
Previous in vitro studies have examined the modulatory effects of the KChIP2 protein on the gating kinetics of Kv4 channels in heterologous expression systems. An et al.28 showed that KChIP proteins may co-localize with Kv4 a-subunits in transiently transfected COS-1 cells. The effects of KChIP1, 2 and 3 may augment A-type currents of Kv4 channels via a variety of mechanisms including increased surface channel density, shifting the activation V1/2 to more negative potentials, and slower inactivation and faster recovery from inactivation in native cells. Schultz et al.31 have recorded whole-cell currents from oocytes injected with porcine Kv4.2 cRNA alone or co-injected with porcine Kv4.2 and porcine KChIP2 cRNA. They found that steady-state inactivation was only marginally, not significantly, affected by KChIP2, whereas the recovery from inactivation was significantly accelerated by co-expressing Kv4.2 with KChIP2.
The reduction in Ito density with the change in channel kinetics in cardiomyocytes from UNx rats and UNx LDL-treated cardiomyocytes suggests that the molecular level of Ito is altered. Previous studies have shown that the differential expression of both KChIP2 and Kv4.2 proteins across the ventricular wall may determine the transmural Ito gradient in mouse, rat, canine, and human hearts32,33,34. In a rat model of type 2 diabetes, Sato et al.34 found an ENDO-predominant prolongation of the APD via a reduction of steady-state Ito induced by type 2 diabetes, in which downregulation of Kv4.2 and KChIP2 proteins may be involved. By using the rat model of early CKD, we discovered an EPI-predominant lengthening of the APD via a reduction of Ito currents in EPI cardiomyocytes secondary to downregulation of KChIP2 without alteration of Kv4.2, Kv4.3, and Kv1.4 protein expression. The reduction of Ito currents caused by KChIP2 deficiency may be attributed to shifting the voltage dependence of inactivation to more hyperpolarized potentials and slower recovery from inactivation as shown in the current and previous studies28,29. Importantly, downregulation of KChIP2 protein abolishes the transmural gradient of Ito leading to increased heterogeneity of repolarization; this may in turn cause unidirectional conduction block, creating a substrate for the reentry circuit and thus increasing susceptibility to malignant ventricular tachyarrhythmias32.
Electronegative LDL may underlie downregulation of KChIP2 protein expression in CKD
It is generally thought that during the course of CKD, the kidney releases mediators that trigger maladaptive myocardial remodeling, ultimately leading to adverse cardiovascular outcomes. In addition to the well-known inflammatory mediators35, we recently discovered that dyslipidemia may be an important upstream mediator of diastolic left ventricular dysfunction in the early stages of CKD15. LDL abnormality is a primary etiology of cardiovascular disease caused by dyslipidemia36. However, extensive lowering of plasma LDL does not prevent cardiovascular events in all patients. This prompted us to identify a culprit pathogenic LDL subfraction.
Our previous study has shown that increased LDL electronegativity in CKD disturbs intracellular calcium homeostasis resulting in cardiac diastolic dysfunction15. We have also found that electronegative LDL increases coronary artery disease risk in patients with uremia who are on maintenance hemodialysis37. In the current study, we demonstrate that the QT interval was prolonged in UNx rats when compared to the sham group. Incubation of normal cardiomyocytes with UNx LDL, which is more electronegative, reproduced a similar electrophysiological phenotype to that seen in UNx rat cardiomyocytes. Importantly, we have shown for the first time that electronegative LDL may underlie the electrophysiological remodeling via downregulation of KChIP2 protein expression in EPI cardiomyocytes with resultant parallel changes of the Ito current and altered channel kinetics in CKD. The disruption of the normal transmural gradient of Ito via downregulation of KChIP2 protein expression in combination with altered SERCA2a-regulated calcium homeostasis15 may further promote susceptibility to ventricular tachyarrhythmias in CKD.
In previous studies, we have shown that the electronegativity of LDL is increased in metabolic disorders and cardiovascular diseases, such as hypercholesterolemia, diabetes, metabolic syndrome, hypertension, myocardial infarction, and stroke38,39,40,41,42,43,44. However, in our UNx model, the rats did not show arterial hypertension, myocardial fibrosis, hyperglycemia, or gross structural heart disease15. Therefore, the increased LDL electronegativity in UNx-induced CKD may be a primary mediator of the electrophysiological remodeling rather than it being mediated secondarily through a common downstream effector pathway of general cardiovascular/metabolic disorders associated with CKD. Furthermore, the direct effects of small particles on ion channels usually occur within minutes of exposure. In the present study, none of the ion currents was altered within 10 minutes in UNx LDL-treated cardiomyocytes compared to controls; this finding indicates that it is unlikely that the effect of CKD-electronegative LDL on Ito/APD is caused by a direct interaction of LDL on the ion channels, but rather it is caused by other indirect pathways. We have previously shown that the effect of electronegative LDL on vascular endothelial cells is mediated by the lectin-like oxidized LDL receptor (LOX-1). This could also be how electronegative LDL exerts its effects on cardiomyocytes, resulting in electrophysiological changes in CKD. The downstream signaling is still under investigation, but epigenetic regulation may be a possible mechanism39.
Limitations
This study was undertaken to assess electrophysiological remodeling in early-stage CKD, which developed 8 weeks after UNx. We do not know if the changes in electrophysiological properties will remain constant or become adapted or maladapted in a more chronic scenario. However, the current UNx model is representative of an early, mild form of renal dysfunction; longer observation periods may show fibrosis and hypertrophy of the hearts, which may overtake the effects of early CKD on electrophysiological remodeling. Another limitation of our study is the significant difference in cardiac electrophysiology between rats and humans; rats have a higher heart rate, a more rapid repolarization, and a predominance of Ito over other repolarizing currents compared with humans. Further studies in larger mammal models are necessary to confirm our findings. Furthermore, because only limited amounts of LDL can be isolated from animals, we examined the effects of electronegative LDL on electrophysiological remodeling by incubating cardiomyocytes with UNx LDL instead of by directly injecting LDL into animals. Lastly, although we have identified a disruption in the normal transmural gradient of Ito in the current study and an altered intracellular calcium homeostasis in our previous study (which may sufficiently form a vulnerable ventricular substrate to generate ventricular tachyarrhythmias10,15,32), we did not perform a programmed electrical stimulation study to test the inducibility of ventricular tachyarrhythmias in UNx rats. Indeed, further studies are necessary to combine multiple modalities, including patch-clamp techniques, optical mapping, inserted loop recorders for arrhythmias detection, and programmed electrical stimulation, to investigate the electrophysiological substrate and susceptibility to ventricular arrhythmias in CKD.
Conclusions
The results of our study indicate that CKD is associated with EPI-predominant prolongation of the APD and disruption of the physiological transmural gradient of Ito via downregulation of KChIP2 protein expression in the EPI region, which together may promote susceptibility to ventricular tachyarrhythmias. Electronegative LDL may underlie the downregulation of KChIP2 and the resultant electrophysiological remodeling in CKD.
Materials and Methods
Rat model of CKD
To characterize electrical changes in early CKD, we used a rat model of early CKD induced by UNx. All animal research was approved by the China Medical University Institutional Animal Care and Use Committee (2016-128), and all procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals by the US National Institutes of Health. Adult male 8-week-old Sprague Dawley rats purchased from BioLASCO Taiwan Co., Ltd. (Taipei, Taiwan) were assigned to 1 of 2 groups: the UNx group or the sham group. All rats were anesthetized with 2% isoflurane (Abbott Laboratories, Abbott Park, IL, USA) and supported by a rodent ventilator (New England Medical Instruments, Medway, MA, USA). For UNx, the left kidney was removed immediately following ligation of the left renal artery and vein using a 4/0 silk suture. After 8 weeks, the biochemical parameters of blood samples including total cholesterol, triglyceride, LDL, HDL, BUN, and creatinine levels were measured by the Automated Biochemical Analyzer (SP-4430, Spotchem EZ, Arkray USA, Edina, MN, USA) with different strips.
Electrocardiogram
The lead II surface electrocardiogram was recorded 8 weeks after the operation at the sampling rate of 1000 Hz by using PONEMAH real-time acquisition interface P3P Plus coupled to a digital converter (ML-870, ADInstruments, Colorado Springs, CO, USA). Data were analyzed by the software Lab Chart 7 plus (ADInstruments), and all characteristics were measured as the average of five consecutive cycles. The rate-corrected QTc interval was calculated according to the equation:
where QT0, QTc, y, RR100 are the observed QT, rate-corrected QT interval, value of the exponent, and normalized RR interval, respectively17.
Isolation of cardiomyocytes
Left ventricular cardiomyocytes of rats were enzymatically isolated by the Langendorff perfusion method. Hearts were retrogradely perfused with Krebs buffer (in mmole/L): 120 NaCl, 12 glucose, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, and 5.4 KCl; pH was adjusted to 7.4 by using HEPES. After a 5-min equilibration, we added 0.4 mg/mL collagenase (type II, Worthington) for 20 min. Hearts were then dissected from the left ventricular EPI and ENDO layer, leaving a distinct and dividing mid-myocardial layer. Single EPI or ENDO cardiomyocytes were then isolated by digestion with 0.4 mg/mL collagenase and 0.02 mg/mL trypsin (ThermoFisher Scientific, Waltham, MA, USA) in Krebs buffer for 20 min. After filtration, the cardiomyocytes were washed twice with Krebs buffer and stored in Krebs buffer. To examine the direct effect of LDL on control cardiomyocytes, we pretreated the cells with LDL isolated from sham and UNx rats for 12 hours.
Electrophysiological recording
The whole-cell patch-clamp technique was used to record ionic currents and membrane potential with the Axon CNS 700B amplifier (Molecular Devices, LLC, Sunnyvale, CA, USA) with Digidata 1550 A data acquisition system and pClamp software (Version 10, Molecular Devices). A droplet of cell suspension was placed in a chamber mounted on the stage of an inverted microscope (Eclipse Ti-U, Nikon Corporation, Tokyo, Japan) in bath (extracellular) solution containing (in mM/L) 137 NaCl, 5.4 KCl, 1.8 CaCl2, 1.1 MgCl2, 6 HEPES, 22 glucose, and 0.33 NaH2PO4; pH was adjusted to 7.4 using NaOH at room temperature. Only quiescent rod-shaped cells showing clear-cross striations were studied. The mean capacitance of EPI cardiomyocytes from sham and UNx rats was 198.72 ± 20.57 and 192.79 ± 16.74 pF, respectively, and that of ENDO cardiomyocytes was 182.78 ± 12.38 and 186.89 ± 16.85, respectively (n = 20 per group). Heat-polished glass electrodes (tip resistances about 1.5 MΩ when filled with pipette internal solution) were prepared from borosilicate glass capillaries (outer diameter 1.5 mm) by the Glass Microelectrode Puller (PC-10, Narishige International Inc., East Meadow, NY, USA) and polished by the Microforge (MF-830, Narishige). The internal solution contained (in mmol/L) 120 KCl, 5 MgCl2, 5 MgATP, 10 HEPES, and 15 EGTA; the pH was adjusted to 7.2 using KOH at room temperature. Junctional potentials were zeroed before the formation of the membrane-pipette seal in the bath solution. Capacitances of cells were measured by calculating the total charge movement of the capacitative transient in response to a 10 mV hyperpolarizing pulse. Ito was defined as the difference between the peak value and the current level at the end of a 400 ms pulse. The cycle length of the stimulation in action potential measurements was 1000 ms. All patch-clamp experiments were performed at room temperature.
LDL isolation and determination of LDL electronegativity
Rat plasma LDL was isolated by using sequential potassium bromide density-gradient ultracentrifugation (d = 1.030–1.063 g/mL). To confirm the quality and electronegativity of LDL samples, we separated them in 0.7% agarose by using electrophoresis and subjected the delipidated LDL samples to sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Immunoblotting
The left ventricular EPI layer of each UNx and sham rat was homogenized by using a Mini-Beadbeater-1 (BioSpec Products, Inc., Bartlesville, OK, USA) in T-PER Tissue Protein Extraction Reagent. For immunoblotting, polyclonal antibodies against Kv4.2/4.3 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), Kv1.4 (Academy Bio-Medical Company, Houston, TX, USA), KChIP2 (Merck Millipore, Darmstadt, Germany), and β-actin (Sigma Aldrich Corporation, St. Louis, MO, USA) were used.
Statistical analysis
The data are expressed as the mean ± standard error of the mean, and the differences between the 2 groups were determined by using the Mann-Whitney U test. The difference between the mean EPI and ENDO Ito current was plotted as the transmural gradient of Ito. The transmural gradient of Ito between sham and UNx rats was compared by using two-way ANOVA with the post-hoc Bonferroni correction. A P-value < 0.05 was considered statistically significant. The inactivation curve of Ito was fitted by using the Boltzmann equation:
where I gives the current amplitude and Imax its maximum, Vm the potential of pulse, V0.5 the half-maximal inactivation potential, and k the slope factor. The recovery curve of Ito was fitted by the single exponential function:
where τ is the time constant of decaying component of inactivation.
Additional Information
How to cite this article: Lee, A.-S. et al. Electronegative LDL-Mediated Cardiac Electrical Remodeling in a Rat Model of Chronic Kidney Disease. Sci. Rep. 7, 40676; doi: 10.1038/srep40676 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Foley, R. N. et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J. Am. Soc. Nephrol. 16, 489–495, doi: 10.1681/ASN.2004030203 (2005).
Parfrey, P. S. & Foley, R. N. The clinical epidemiology of cardiac disease in chronic renal failure. J. Am. Soc. Nephrol. 10, 1606–1615 (1999).
Bleyer, A. J. et al. Characteristics of sudden death in hemodialysis patients. Kidney Int. 69, 2268–2273, doi: 10.1038/sj.ki.5000446 (2006).
Herzog, C. A. Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int. Suppl., S197–200, doi: 10.1046/j.1523-1755.63.s84.17.x (2003).
Bayes de Luna, A., Coumel, P. & Leclercq, J. F. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am. Heart J. 117, 151–159 (1989).
Pachon, M. & Almendral, J. Sudden death: managing the patient who survives. Heart 97, 1619–1625, doi: 10.1136/hrt.2009.188375 (2011).
Deo, R. et al. Cystatin C and sudden cardiac death risk in the elderly. Circ. Cardiovasc. Qual. Outcomes 3, 159–164, doi: 10.1161/CIRCOUTCOMES.109.875369 (2010).
Lindner, A., Charra, B., Sherrard, D. J. & Scribner, B. H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med. 290, 697–701, doi: 10.1056/NEJM197403282901301 (1974).
Deo, R. et al. Kidney dysfunction and fatal cardiovascular disease–an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. Am. Heart J. 155, 62–68, doi: 10.1016/j.ahj.2007.08.012 (2008).
Hsueh, C. H. et al. Pathogenesis of arrhythmias in a model of CKD. J. Am. Soc. Nephrol. 25, 2812–2821, doi: 10.1681/ASN.2013121343 (2014).
Vaziri, N. D. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am. J. Physiol. Renal Physiol. 290, F262–272, doi: 10.1152/ajprenal.00099.2005 (2006).
Attman, P. O. & Alaupovic, P. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia–relation to renal function and dialysis. Nephron 57, 401–410 (1991).
Quaschning, T., Krane, V., Metzger, T. & Wanner, C. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Am. J. Kidney Dis. 38, S14–19 (2001).
Chan, D. T., Irish, A. B., Dogra, G. K. & Watts, G. F. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis 196, 823–834, doi: 10.1016/j.atherosclerosis.2007.01.023 (2008).
Chang, K. C. et al. Increased LDL electronegativity in chronic kidney disease disrupts calcium homeostasis resulting in cardiac dysfunction. J Mol Cell Cardiol. 84, 36–44 (2015).
Zorn-Pauly, K. et al. Oxidized LDL induces ventricular myocyte damage and abnormal electrical activity–role of lipid hydroperoxides. Cardiovasc. Res. 66, 74–83, doi: 10.1016/j.cardiores.2004.12.009 (2005).
Mitchell, G. F., Jeron, A. & Koren, G. Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol. 274, H747–751 (1998).
Sherif, K. A., Abo-Salem, E., Panikkath, R., Nusrat, M. & Tuncel, M. Cardiac repolarization abnormalities among patients with various stages of chronic kidney disease. Clin. Cardiol. 37, 417–421, doi: 10.1002/clc.22277 (2014).
Tang, W. H. et al. Uremic retention solute indoxyl sulfate level is associated with prolonged QTc interval in early CKD patients. PLoS One 10, e0119545, doi: 10.1371/journal.pone.0119545 (2015).
Tomita, F., Bassett, A. L., Myerburg, R. J. & Kimura, S. Diminished transient outward currents in rat hypertrophied ventricular myocytes. Circ. Res. 75, 296–303 (1994).
Wettwer, E., Amos, G. J., Posival, H. & Ravens, U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ. Res. 75, 473–482 (1994).
Goltz, D. et al. Diminished Kv4.2/3 but not KChIP2 levels reduce the cardiac transient outward K+ current in spontaneously hypertensive rats. Cardiovasc. Res. 74, 85–95, doi: 10.1016/j.cardiores.2007.01.001 (2007).
Shipsey, S. J., Bryant, S. M. & Hart, G. Effects of hypertrophy on regional action potential characteristics in the rat left ventricle: a cellular basis for T-wave inversion? Circulation 96, 2061–2068 (1997).
Li, J. et al. Cold-inducible RNA-binding protein regulates cardiac repolarization by targeting transient outward potassium channels. Circ. Res. 116, 1655–1659, doi: 10.1161/CIRCRESAHA.116.306287 (2015).
Yu, H. et al. Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart. Circ. Res. 86, 1062–1068 (2000).
Cordeiro, J. M. et al. Physiological consequences of transient outward K+ current activation during heart failure in the canine left ventricle. J. Mol. Cell. Cardiol. 52, 1291–1298, doi: 10.1016/j.yjmcc.2012.03.001 (2012).
Dixon, J. E. & McKinnon, D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats. Circ. Res. 75, 252–260 (1994).
An, W. F. et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature 403, 553–556, doi: 10.1038/35000592 (2000).
Bahring, R. et al. Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating. J. Biol. Chem. 276, 23888–23894, doi: 10.1074/jbc.M101320200 (2001).
Wible, B. A., Yang, Q., Kuryshev, Y. A., Accili, E. A. & Brown, A. M. Cloning and expression of a novel K+ channel regulatory protein, KChAP. J. Biol. Chem. 273, 11745–11751 (1998).
Schultz, J. H. et al. Molecular and functional characterization of Kv4.2 and KChIP2 expressed in the porcine left ventricle. Pflugers Arch. 454, 195–207, doi: 10.1007/s00424-006-0203-1 (2007).
Kuo, H. C. et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 107, 801–813 (2001).
Patel, S. P., Campbell, D. L., Morales, M. J. & Strauss, H. C. Heterogeneous expression of KChIP2 isoforms in the ferret heart. J Physiol 539, 649–656 (2002).
Sato, T. et al. Type 2 diabetes induces subendocardium-predominant reduction in transient outward K+ current with downregulation of Kv4.2 and KChIP2. Am. J. Physiol. Heart Circ. Physiol. 306, H1054–1065, doi: 10.1152/ajpheart.00414.2013 (2014).
Bock, J. S. & Gottlieb, S. S. Cardiorenal syndrome: new perspectives. Circulation 121, 2592–2600, doi: 10.1161/CIRCULATIONAHA.109.886473 (2010).
Lipinski, M. J. et al. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am. J. Cardiol. 104, 1708–1716, doi: 10.1016/j.amjcard.2009.07.055 (2009).
Chang, C. T. et al. Electronegative low-density lipoprotein increases coronary artery disease risk in uremia patients on maintenance hemodialysis. Medicine (Baltimore). 95, e2265, doi: 10.1097/MD.0000000000002265 (2016).
Chan, H. C. et al. Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood 122, 3632–3641, doi: 10.1182/blood-2013-05-504639 (2013).
Chang, P. Y. et al. Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction. Cardiovasc. Res. 99, 137–145, doi: 10.1093/cvr/cvt062 (2013).
Chen, C. H. et al. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 107, 2102–2108, doi: 10.1161/01.CIR.0000065220.70220.F7 (2003).
Lu, J. et al. Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation. Diabetes 57, 158–166, doi: 10.2337/db07-1287 (2008).
Lu, J. et al. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ. Res. 104, 619–627, doi: 10.1161/CIRCRESAHA.108.190116 (2009).
Shen, M. Y. et al. Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation. Blood 127, 1336–1345, doi: 10.1182/blood-2015-05-646117 (2016).
Tang, D. et al. Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. J. Lipid Res. 49, 33–47, doi: 10.1194/jlr.M700305-JLR200 (2008).
Acknowledgements
The authors thank Rebecca Bartow, PhD, at the Texas Heart Institute, Houston, Texas, for editorial assistance. This study is supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), the Taiwan National Health Research Institutes (NHRI-EX103-10305SI, NHRI-EX104-10305SI, NHRI-EX105-10305SI), the Taiwan Ministry of Science and Technology (MOST-105-2314-B-039-041, MOST-104-2320-B-715-009-MY3, MOST-104-2314-B-039-048, MOST-103-2314-B-715-008, and MOST-103-2314-B-039-029), Vascular and Medicinal Research Fund, Texas Heart Institute, #765-64050, Houston, Texas, USA, Kaohsiung Medical University grant, KMU-TP104D00, Kaohsiung, Taiwan, and Mackay Medical College in Taiwan (1021A06, 1031B14, 1041B08).
Author information
Authors and Affiliations
Contributions
K.C.C. and A.S.L. designed research; A.S.L., W.Y.C., H.C.C., C.H. Chung, H.Y.P., and C.M.C.- perform the experiments; A.S.L. and K.C.C. analyzed the data and wrote the paper; M.J.S. and C.H. Chen reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Lee, AS., Chen, WY., Chan, HC. et al. Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease. Sci Rep 7, 40676 (2017). https://doi.org/10.1038/srep40676
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep40676
This article is cited by
-
The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23
BMC Medicine (2022)
-
Human electronegative low-density lipoprotein modulates cardiac repolarization via LOX-1-mediated alteration of sarcolemmal ion channels
Scientific Reports (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.